The Principal Scientist will lead Emerging Therapies projects related to intellectual property (IP) development, awareness of industry trends, and technology evaluation initiatives, requiring a scientifically rigorous professional who combines deep technical expertise, business acumen, and long-term vision to inform organizational decisions. A primary focus of this position is IP, working under the direction of Emerging Therapies leadership and collaborating with IP counsel to strengthen the company's competitive position. The Principal Scientist will critically evaluate scientific literature and emerging technologies, translating complex analyses into actionable insights for diverse stakeholders across the organization.
RESPONSIBILITIES
Requirements
KNOWLEDGE AND SKILL REQUIREMENTS
Experience, Competencies, Education:
WORKING CONDITIONS

SPR is a privately held medical device company, providing patients with a non-opioid, minimally invasive pain treatment option. Our SPRINT® PNS System fulfills a critical unmet need for a drug-free, surgery-free option for millions who suffer from chronic pain. Backed by the largest body of clinical evidence in peripheral nerve stimulation for the treatment of pain, SPR has demonstrated commercial demand in untapped peripheral (shoulder and knee) and back pain markets and built an incredibly strong foundation for commercial growth. Headquartered in Cleveland, OH with satellite offices in Chapel Hill, NC and Minneapolis, MN, SPR’s Senior Management team includes experienced industry veterans with nearly 200 years of collective pain market and MedTech expertise, all driven by our purpose – to improve the quality of patients’ lives by providing them with a minimally-invasive, drug-free, surgery-free solution to manage their acute and chronic pain. SPR® – Solutions for pain. Inspired by life. ™
Short-term treatment. Designed for long-term relief.™
The SPRINT® PNS System, by SPR, marks an innovative shift in the treatment of pain. Our breakthrough, 60-day treatment is a First-Line™ PNS option uniquely proposed to recondition the central nervous system to provide significant and sustained relief from chronic pain — without a permanent implant, nerve destruction or the risk of addiction. The system has been studied extensively for low back pain, shoulder pain, post-amputation pain, and chronic and acute post-operative pain, and is cleared for use up to 60 days. Recognized by leading pain management centers, this breakthrough neuromodulation treatment offers a patient-preferred alternative to more invasive options.